US 12162950
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
granted A61KA61K2039/505A61K2039/6081
Quick answer
US patent 12162950 (Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis) held by The Regents of the University of California expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/6081, A61K39/001102, A61P